Ceramidase, glucosyl- (human HT-1080 cell)(884604-91-5)
- Name: Ceramidase, glucosyl- (human HT-1080 cell)
- Synonyms:Velaglucerase alfa;
- Molecular Formula:
- Molecular Weight:
- CAS Registry Number:884604-91-5
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 918127-53-4/Immunoglobulin G1, anti-(human cytokine receptor DR5 (death receptor 5)) (human-mouse monoclonal TRA-8 γ1-chain), disulfide with human-mouse monoclonal TRA-8 κ-chain, dimer
- 903512-50-5/Immunoglobulin G1, anti-(human CD40 (antigen)) (human monoclonal CHIR-12.12 heavy chain), disulfide with human monoclonal CHIR-12.12 light chain, dimer (9CI)
- 640735-09-7/Immunoglobulin G1, anti-(human CD30 (antigen)) (human monoclonal MDX-060 heavy chain), disulfide with human monoclonal MDX-060 light chain, dimer
- 680188-33-4/Immunoglobulin G4, anti-(human CD4 (antigen)) (human-mouse monoclonal 5A8 γ4-chain), disulfide with human-mouse monoclonal 5A8 κ-chain, dimer
- 402710-25-2/Immunoglobulin G1, anti-(human interleukin 1β) (human clone ACZ885 heavy chain V region) (9CI)
- 402710-27-4/Immunoglobulin, G1 anti-(human interleukin 1β) (human clone ACZ885 light chain V region) (9CI)
- 185954-75-0/1-Decanol, 3-methoxy-, (3R)-
- 281214-27-5/1,4-Butanediol, 2,3-dimethyl-, 1,4-bis(4-methylbenzenesulfonate), (2R,3R)-
- 884604-91-5/Ceramidase, glucosyl- (human HT-1080 cell)
- 885051-90-1/Pegloticase
- 892497-01-7/1,4-Diazabicyclo[2.2.2]octane, homopolymer, N-oxides, bromoacetic acid-quaternized
- 898830-54-1/Sitimagene ceradenovec
- 869881-54-9/Cytokine receptor BAFF-R (human extracellular domain-containing fragment BR3) fusion protein with immunoglobulin G1 (human Fc domain-containing fragment), dimer
- 295371-00-5/Heat-shock protein HSP 65 (Mycobacterium bovis strain BCG) fusion protein with transcription factor E7 (human papillomavirus 16) (9CI)
- 473553-86-5/DNA (synthetic human adenovirus 5 human fibroblast growth factor 4 gene-containing 35506-nucleotide fragment ZK 205368)
- 1345973-49-0/AB-001
- 76610-92-9/(6R,7S)-7-[[(2R,3S)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarbonylamino)-3-hydroxybutyryl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 893428-72-3/4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2)
- 149456-98-4/Methanesulfonamide, N-[4-[2-(formylamino)acetyl]-5-methoxy-2-phenoxyphenyl]-
- 149457-03-4/Methanesulfonamide, N-[4-[2-(formylamino)acetyl]-5-hydroxy-2-phenoxyphenyl]-
- 1198178-65-2/Cyclopropanecarboxamide, 1-amino-N-(cyclopropylsulfonyl)-2-ethyl-, (1R,2R)-, 4-methylbenzenesulfonate (1:1)
- 120788-03-6/Ethanethioic acid, S-(tetrahydro-1-oxido-3-thienyl) ester, (1R-cis)- (9CI)
- 780758-10-3/Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-mouse h-R3 heavy chain), disulfide with human-mouse h-R3 κ-chain, dimer
- 945228-49-9/Immunoglobulin G, anti-(tumor antigen 17-1A) (synthetic Fab fragment) fusion protein with bouganin (synthetic deimmunized)
- 910649-32-0/Immunoglobulin G1, anti-(human interleukin 13) (human-mouse heavy chain), disulfide with human-mouse κ-chain, dimer
- 880486-59-9/Immunoglobulin G1, anti-(human CD40 (antigen)) (human-mouse monoclonal SGN-40 γ1-chain), disulfide with human-mouse monoclonal SGN-40 κ-chain, dimer
- 615258-40-7/Denosumab (usan)
- 676258-98-3/Naptumomab estafenatox
- 477202-00-9/ipilimumab
- 899796-83-9/MilatuzuMab